Live News EQUITY FLASH L impact Sep 30, 2026, 06:19 PM UTC Sarepta Therapeutics Maintained Neutral by JP Morgan JP Morgan maintained its Neutral rating on Sarepta Therapeutics. SRPT SquawkNews Desk